PR Newswire Asia's news > Health Care/Hospital

 < Previous page   |   Detail   |   Print    Next page > 
     
Priority Review Granted to PD-L1/4-1BB Bispecific Antibody Opamtistomig, Accelerating Commercialization and Addressing Unmet Need in EP-NEC
2026-07-10T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Insilico Medicine Releases Positive Profit Alert for the First Half of 2026
2026-07-09T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Lynk Pharmaceuticals Announces First Patient Dosed in Phase II Clinical Trial of LNK01004 Ointment for Vitiligo
2026-07-09T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
On the Eve of BIO 2026, Chinese Innovative Assets Trigger a New Wave of Global Collaborations
2026-07-09T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Tsingke Highlights AI-Driven CLDN18.2 Antibody Discovery at AIS 2026
2026-07-08T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Vermon launches Vermon Group, accelerating its growth and expanding its offerings
2026-07-08T    Computer/Electronics   Health Care/Hospital   Medical Equipment 
Altruist Biologics' Hangzhou Antibody-Drug Conjugate Facility Receives Provincial Regulatory Approval for Segmented Production
2026-07-08T    Health Care/Hospital   Medical/Pharmaceuticals 
Global Care Economy Set to Create Significant Growth Opportunities as Care-Dependent Population Reaches up to 4.6 Billion by 2035
2026-07-08T    Computer Software   Computer/Electronics   Health Care/Hospital 
Seegene Launches Industry's First Global Million Clinical Study to Shape New Disease-Specific Testing Standards
2026-07-08T    Health Care/Hospital   Medical/Pharmaceuticals 
BB Energy Secures Three Additional South Sudan Crude Oil Cargoes
2026-07-08T    Banking/Financial Service   Health Care/Hospital   Oil/Energy 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.